Trial intelligence / Profile preview

Anastrozole Sequencing With Radiotherapy in Breast Cancer (STARS-Pilot)

NCT00126360Phase 4Unknown

Sponsor
St George Hospital
Start
Aug 2005
Modality
Irreversible Covalent Inhibitors, Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial of anastrozole in breast cancer, sponsored by St George Hospital. Primary endpoint: Local failure within irradiation volume. Status: unknown.

02

Drugs

anastrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00126360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00126360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call